Cargando…

Altered pathways and targeted therapy in double hit lymphoma

High-grade B-cell lymphoma with translocations involving MYC and BCL2 or BCL6, usually referred to as double hit lymphoma (DHL), is an aggressive hematological malignance with distinct genetic features and poor clinical prognosis. Current standard chemoimmunotherapy fails to confer satisfying outcom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhuang, Yuxin, Che, Jinxin, Wu, Meijuan, Guo, Yu, Xu, Yongjin, Dong, Xiaowu, Yang, Haiyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8932183/ https://www.ncbi.nlm.nih.gov/pubmed/35303910 http://dx.doi.org/10.1186/s13045-022-01249-9

Ejemplares similares

Peripheral immune cell profiling of double-hit lymphoma by mass cytometry
por: Lei, Tao, et al.
Publicado: (2023)

Drug therapy for double-hit lymphoma
por: Phuoc, Vania, et al.
Publicado: (2019)

Rational targeted therapeutics for double-hit lymphoma
por: Azizian, Nancy G, et al.
Publicado: (2019)

Advancing the management of double hit lymphoma
por: Landsburg, Daniel J.
Publicado: (2017)

Pharmacological targeting PIKfyve and tubulin as an effective treatment strategy for double-hit lymphoma
por: Feng, Liying, et al.
Publicado: (2022)

Tolosa-Hunt Syndrome in Double-Hit Lymphoma
por: Peddi, Prakash, et al.
Publicado: (2015)

Targeting MYC and BCL2 by a natural compound for “double‐hit” lymphoma
por: Liu, Xiaoqian, et al.
Publicado: (2022)

Activation-induced cytidine deaminase overexpression in double-hit lymphoma: potential target for novel anticancer therapy
por: Zhang, Jingcheng, et al.
Publicado: (2020)

Flow Cytometric Evaluation of Double/Triple Hit Lymphoma
por: Roth, Christine G., et al.
Publicado: (2016)

Hepatitis C and double-hit B cell lymphoma successfully treated by antiviral therapy
por: Galati, Giovanni, et al.
Publicado: (2016)

Double-hit lymphoma of the male breast: a case report
por: Elgaafary, Shaymaa, et al.
Publicado: (2020)

Simultaneous targeting of XPO1 and BCL2 as an effective treatment strategy for double-hit lymphoma
por: Liu, Yuanhui, et al.
Publicado: (2019)

Diagnostic Approach for Double-Hit and Triple-Hit Lymphoma Based on Immunophenotypic and Cytogenetic Characteristics of Bone Marrow Specimens
por: Kim, Heyjin, et al.
Publicado: (2020)

Establishment and characterization of a novel ‘double‐hit’ follicular lymphoma cell line, FL‐SJC
por: Chen, Min, et al.
Publicado: (2020)

Clinical Significance of “Double-hit” and “Double-protein” expression in Primary Gastric B-cell Lymphomas
por: He, Miaoxia, et al.
Publicado: (2016)

Ataxia's double hit
por: Leslie, Mitch
Publicado: (2010)

Prognostic impact of history of follicular lymphoma, induction regimen and stem cell transplant in patients with MYC/BCL2 double hit lymphoma
por: Li, Shaoying, et al.
Publicado: (2016)

Cutaneous presentation of Double Hit Lymphoma: A Case Report With Review of the Literature
por: Khelfa, Yousef, et al.
Publicado: (2016)

Clinical Features and Immunophenotypes of Double-Hit Diffuse Large B-Cell Lymphoma
por: Wu, Cheng-Han, et al.
Publicado: (2022)

Transformation of double-hit follicular lymphoma to plasmablastic lymphoma: a partial role of MYC gene rearrangement
por: Ise, Mikiko, et al.
Publicado: (2018)

Assessment of CD52 expression in "double-hit" and "double-expressor" lymphomas: Implications for clinical trial eligibility
por: Craig, Jeffrey W., et al.
Publicado: (2018)

Prognostic impact of diffuse large B-cell lymphoma with extra copies of MYC, BCL2 and/or BCL6: comparison with double/triple hit lymphoma and double expressor lymphoma
por: Huang, Sixia, et al.
Publicado: (2019)

Bruton’s tyrosine kinase inhibitors in primary central nervous system lymphoma—evaluation of anti-tumor efficacy and brain distribution
por: Yu, Haifeng, et al.
Publicado: (2021)

Unusual presentation of extra-nodal double-hit follicular lymphoma: a case report
por: Lazzi, Stefano, et al.
Publicado: (2022)

P1674: CLINICAL IMPACT OF NON-ADHERENCE TO HIT GUIDELINES: A DOUBLE HIT IN HIT
por: Al Raizah, A., et al.
Publicado: (2022)

Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors
por: Li, Weiping, et al.
Publicado: (2019)

“Double hit” makes the difference
por: Bost, Frédéric
Publicado: (2012)

Human Papillomavirus and Cellular Pathways: Hits and Targets
por: Medda, Alessandro, et al.
Publicado: (2021)

BFL-1 expression determines the efficacy of venetoclax in MYC+/BCL2+ double hit lymphoma
por: Esteve-Arenys, Anna, et al.
Publicado: (2018)

Primary breast double-hit lymphoma management and outcomes: a real-world multicentre experience
por: Zhang, Tingting, et al.
Publicado: (2021)

Double-hit lymphoma (rearrangements of MYC, BCL-2) during pregnancy: A case report
por: Xie, Fan, et al.
Publicado: (2021)

Double‑hit primary lymphoma (MYC and BCL2) in the bilateral ovary: A case report
por: Zhang, Yan, et al.
Publicado: (2023)

De Novo CD5-Positive Primary Gastric Diffuse Large B-Cell Lymphoma Coexpressing MYC and BCL6: Towards a Proper Subset of Double-Hit, Triple-Hit and, Maybe, Quadruple-Hit B-Cell Lymphomas?
por: Roncati, Luca
Publicado: (2018)

Double hit of NEMO gene in preeclampsia
por: Sakowicz, Agata, et al.
Publicado: (2017)

Educational Case: Gastric High-Grade B-Cell Lymphoma With MYC and BCL2 Gene Rearrangement (Double-Hit Lymphoma)
por: Betts, Elham Vali, et al.
Publicado: (2020)

Autologous peripheral blood stem cell transplantation as front-line therapy for myeloma with double-hit and triple-hit in a real-world study
por: Yang, Guang-Zhong, et al.
Publicado: (2021)

Clinical and Pathological Features of Double-Hit and Triple-Hit High-Grade B-Cell Lymphomas: A Retrospective Study from Three Portuguese Tertiary Centers
por: Almeida, Rui, et al.
Publicado: (2022)

Double-hit and double-expressor primary central nervous system lymphoma: Experience from North India of an infrequent but aggressive variant
por: Parkhi, Mayur, et al.
Publicado: (2023)

Genetic characterization and drug sensitivity study of newly derived HGBL double/triple-hit lymphoma cell lines
por: Zhang, Jibin, et al.
Publicado: (2022)

Double Hit Lymphoma – a Case of Unusual Response After Sequential Aggressive Chemotherapy and Review of the Literature
por: Cheema, Faisal N, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_i1tf47anrehnll4h50emfhp4lb